Cargando…

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa

BACKGROUND: Epidermolysis bullosa (EB), a severe genetic disorder characterized by blister formation in skin, is caused by mutations in genes encoding dermal-epidermal junction proteins that function to hold the skin layers together. CRISPR/Cas9-induced homology-directed repair (HDR) represents a pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petković, Igor, Bischof, Johannes, Kocher, Thomas, March, Oliver Patrick, Liemberger, Bernadette, Hainzl, Stefan, Strunk, Dirk, Raninger, Anna Maria, Binder, Heide-Marie, Reichelt, Julia, Guttmann-Gruber, Christina, Wally, Verena, Piñón Hofbauer, Josefina, Bauer, Johann Wolfgang, Koller, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454317/ https://www.ncbi.nlm.nih.gov/pubmed/36091706 http://dx.doi.org/10.3389/fmed.2022.976604

Ejemplares similares

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022)

A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
por: Kocher, Thomas, et al.
Publicado: (2021)

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents
por: Liemberger, Bernadette, et al.
Publicado: (2023)

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies
por: Bornert, Olivier, et al.
Publicado: (2019)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

An ex vivo RNA trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
por: Peking, P., et al.
Publicado: (2018)

Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
por: Guttmann-Gruber, Christina, et al.
Publicado: (2018)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020)

An RNA-targeted therapy for dystrophic epidermolysis bullosa
por: Peking, Patricia, et al.
Publicado: (2017)

Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination
por: Kocher, Thomas, et al.
Publicado: (2019)

MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex
por: Lettner, Thomas, et al.
Publicado: (2013)

Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
por: Guttmann-Gruber, Christina, et al.
Publicado: (2021)

Epidermolysis bullosa: Advances in research and treatment
por: Prodinger, Christine, et al.
Publicado: (2019)

Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa
por: Fuentes, Ignacia, et al.
Publicado: (2020)

Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
por: Wally, Verena, et al.
Publicado: (2013)

Independent COL17A1 Variants in Cats with Junctional Epidermolysis Bullosa
por: Kiener, Sarah, et al.
Publicado: (2023)

An Incompletely Penetrant Novel Mutation in COL7A1 Causes Epidermolysis Bullosa Pruriginosa and Dominant Dystrophic Epidermolysis Bullosa Phenotypes in an Extended Kindred
por: Yang, Catherine S, et al.
Publicado: (2012)

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
por: Kocher, Thomas, et al.
Publicado: (2017)

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
por: Aushev, Magomet, et al.
Publicado: (2017)

Inherited epidermolysis bullosa
por: Fine, Jo-David
Publicado: (2010)

Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018)

Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022)

Autosomal dominant mutation in COL7A1 gene causing epidermolysis bullosa dystrophica
por: Sheth, Jayesh, et al.
Publicado: (2014)

Novel biallelic variants in COL7A1 cause recessive dystrophic epidermolysis bullosa
por: Yang, Neng, et al.
Publicado: (2020)

A Case of Pretibial Epidermolysis Bullosa with Novel Mutations of the COL7A1 Gene
por: Shimizu, Yuri, et al.
Publicado: (2022)

A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020)

The Epidermolysis bullosa house in Salzburg
por: Pohla-Gubo, Gabriela
Publicado: (2010)

Pretibial dystrophic epidermolysis bullosa
por: Callegaro, Elisabeth de Albuquerque Cavalcanti, et al.
Publicado: (2017)

Revertant Mosaicism in Epidermolysis Bullosa
por: Meyer-Mueller, Cameron, et al.
Publicado: (2022)

Familial Epidermolysis Bullosa Pruriginosa
por: Trivedi, Madhvi, et al.
Publicado: (2022)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023)

Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations
por: Tockner, B, et al.
Publicado: (2016)

Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
por: Wally, Verena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kma5n02fgbu4s83vo8na8d29rk